ClinicalTrials.Veeva

Menu

A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder (CNT)

Auburn University logo

Auburn University

Status

Enrolling

Conditions

Alcohol Use Disorder

Treatments

Behavioral: Realtime fMRI Neurofeedback - Active
Behavioral: Realtime fMRI Neurofeedback - Yoked Sham
Device: TMS - Sham
Device: TMS - Active

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05621538
R00AA027830 (U.S. NIH Grant/Contract)
22145

Details and patient eligibility

About

The goal of this clinical study is to test the effectiveness of a supplemental fMRI neurofeedback and/or TMS intervention in individuals seeking treatment for Alcohol Use Disorder.

After an initial visit, participants will come in once a week for four (4) weeks for an intervention session, which may or may not include TMS and MRI. Participants will be contacted for monthly follow-ups (remotely) for up to 12 months and will be asked to come in for two MRI follow-ups at 6 and 12 months.

Enrollment

90 estimated patients

Sex

All

Ages

19 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 19-65
  2. Receiving treatment for Alcohol Use Disorder

Exclusion criteria

  1. MRI Contraindications

    1. Presence of metal in the body that would make having a 7T MRI unsafe (including facial tattoos)
    2. Claustrophobia, such that individual would be unable to stay in the MRI for up to 1 hr
    3. Hearing loss, including tinnitus, that might be made worse by MRI or TMS
  2. TMS Contraindications

    1. Has ever had a seizure, or has a family history of epilepsy
    2. Taking medications or substances that lower the seizure threshold
    3. Implanted devices that are in the head or rely on physiological signals
    4. History of neurological disease, such as stroke or brain tumor
    5. Head injury with loss of consciousness greater than 30 minutes
    6. Actively withdrawing from alcohol
  3. Family history of schizophrenia or presence of psychotic symptoms

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Triple Blind

90 participants in 5 patient groups

Neurofeedback-active + TMS-active
Experimental group
Description:
4 sessions of: TMS (protocol: 10 Hz pulses delivered at 110% of MT in 60 x 5 sec trains with 25 sec ITI) Neurofeedback (protocol: presentation of own brain activity from multiple ROIs measured using fMRI)
Treatment:
Device: TMS - Active
Behavioral: Realtime fMRI Neurofeedback - Active
Neurofeedback-active + TMS-sham
Active Comparator group
Description:
4 sessions of: TMS (protocol: 10 Hz pulses delivered using the Sham TMS coil in 60 x 5 sec trains with 25 sec ITI) Neurofeedback (protocol: presentation of own brain activity from multiple ROIs measured using fMRI)
Treatment:
Device: TMS - Sham
Behavioral: Realtime fMRI Neurofeedback - Active
Neurofeedback-sham + TMS-active
Active Comparator group
Description:
4 sessions of: TMS (protocol: 10 Hz pulses delivered at 110% of MT in 60 x 5 sec trains with 25 sec ITI) Neurofeedback (protocol: presentation of other's brain activity from multiple ROIs measured using fMRI)
Treatment:
Device: TMS - Active
Behavioral: Realtime fMRI Neurofeedback - Yoked Sham
Neurofeedback-sham + TMS-sham
Sham Comparator group
Description:
4 sessions of: TMS (protocol: 10 Hz pulses delivered using the Sham TMS coil in 60 x 5 sec trains with 25 sec ITI) Neurofeedback (protocol: presentation of other's brain activity from multiple ROIs measured using fMRI)
Treatment:
Device: TMS - Sham
Behavioral: Realtime fMRI Neurofeedback - Yoked Sham
Check-In Only
No Intervention group
Description:
4 sessions of: Completing typical pre-TMS/MRI procedures Being prompted to reflect on outside treatment (TAU)

Trial contacts and locations

1

Loading...

Central trial contact

SCAMPI Lab

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems